I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rojavin, Mikhail
69
results:
Search for persons
X
Format
Online (69)
Mediatypes
Articles (Online) (65)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
Systemic IgG Exposure and Safety in Patients with Primary I..:
Wasserman, Richard L
;
Cunningham-Rundles, Charlotte
;
Anderson, John
...
Immunotherapy. 14 (2022) 16 - p. 1315-1328 , 2022
Link:
https://doi.org/10.2217/..
?
2
Safety and Tolerability of Subcutaneous IgPro20 at High Inf..:
Anderson, John T.
;
Bonagura, Vincent R.
;
Cowan, Juthaporn
...
Journal of Clinical Immunology. 41 (2021) 2 - p. 458-469 , 2021
Link:
https://doi.org/10.1007/..
?
3
Safety and tolerability of IgPro10 in Japanese primary immu..:
Morio, Tomohiro
;
Gotoh, Kenji
;
Imagawa, Tomoyuki
...
International Journal of Hematology. 113 (2021) 6 - p. 921-929 , 2021
Link:
https://doi.org/10.1007/..
?
4
Pharmacometric Analysis of IgPro10 in Japanese and Non-Japa..:
Luo, Dandan
;
Baheti, Gautam
;
Tortorici, Michael A.
..
Clinical Therapeutics. 42 (2020) 1 - p. 196-209.e5 , 2020
Link:
https://doi.org/10.1016/..
?
5
Feasibility of Subcutaneous IgPro20 Administration via Manu..:
Cowan, Juthaporn
;
Bonagura, Vincent
;
Hu, Chengping
...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB217 , 2020
Link:
https://doi.org/10.1016/..
?
6
Safety Profile of High IgPro20 Infusion Parameters in Patie..:
Rojavin, Mikhail
;
Hu, Chengping
;
Anderson, John
...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB32 , 2020
Link:
https://doi.org/10.1016/..
?
7
The HILO Study: High Volumes and Flow Rates of Subcutaneous..:
Anderson, John
;
Bonagura, Vincent
;
Cowan, Juthaporn
...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB216 , 2020
Link:
https://doi.org/10.1016/..
?
8
Safety and Tolerability of Manual Push Administration of Su..:
Cowan, Juthaporn
;
Bonagura, Vincent R.
;
Lugar, Patricia L.
...
Journal of Clinical Immunology. 41 (2020) 1 - p. 66-75 , 2020
Link:
https://doi.org/10.1007/..
?
9
Population pharmacokinetic analysis of weekly and biweekly ..:
Zhang, Ying
;
Baheti, Gautam
;
Chapdelaine, Hugo
...
International Immunopharmacology. 81 (2020) - p. 106005 , 2020
Link:
https://doi.org/10.1016/..
?
10
Tolerability of Higher Than Current Infusion Rate and Volum..:
Rojavin, Mikhail A.
;
Hofmann, Jutta
;
Praus, Michaela
Journal of Allergy and Clinical Immunology. 143 (2019) 2 - p. AB114 , 2019
Link:
https://doi.org/10.1016/..
?
11
Privigen® has similar pharmacokinetic properties in primary..:
Tortorici, Michael A.
;
Lawo, John-Philip
;
Weide, Rudolf
...
International Immunopharmacology. 66 (2019) - p. 119-126 , 2019
Link:
https://doi.org/10.1016/..
?
12
Serum Immunoglobulin Trough Levels Following Immunoglobulin..:
Berger, Mel
;
Praus, Michaela
;
Hofmann, Jutta
.
Journal of Allergy and Clinical Immunology. 143 (2019) 2 - p. AB14 , 2019
Link:
https://doi.org/10.1016/..
?
13
Pharmacokinetic properties of Privigen® in Japanese patient..:
Morio, Tomohiro
;
Baheti, Gautam
;
Tortorici, Michael A.
..
Immunological Medicine. 42 (2019) 4 - p. 162-168 , 2019
Link:
https://doi.org/10.1080/..
?
14
Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 ..:
Rojavin, Mikhail A.
;
Chapdelaine, Hugo
;
Tortorici, Michael A.
...
Clinical Pharmacology in Drug Development. 9 (2019) 6 - p. 664-670 , 2019
Link:
https://doi.org/10.1002/..
?
15
Long-Term Efficacy and Safety of Hizentra® in Patients with..:
Jolles, Stephen
;
Rojavin, Mikhail A.
;
Lawo, John-Philip
...
Journal of Clinical Immunology. 38 (2018) 8 - p. 864-875 , 2018
Link:
https://doi.org/10.1007/..
1-15